Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 49 (1) , 37-41
- https://doi.org/10.1016/s0015-0282(16)59644-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosisGynecological Endocrinology, 1987
- The use of CA-125 in the diagnosis and management of endometriosisFertility and Sterility, 1986
- CA-125 levels in endometriosisFertility and Sterility, 1986
- Serum levels of CA-125 in patients with endometriosis: a preliminary reportFertility and Sterility, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancyCancer, 1986
- Monitoring Epithelial Ovarian CancerLaboratory Medicine, 1985
- Short‐term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β‐hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinomaInternational Journal of Cancer, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Progestational activity of Danazol in the human female subjectAmerican Journal of Obstetrics and Gynecology, 1976